Recent Advances in the Treatment of Endometriosis

SERMs
PRMs
Laparoscopic surgery
Surgery and hormonal treatment
Conclusion 
References
Further reading 


Endometriosis is an estrogen-dependent disease characterized by the presence of endometrial tissue outside of the uterus that occurs mainly in menstruating women. Both glands and stroma grow in lesions outside of the uterine cavity. These lesions grow and spread as a result of the hormone estrogen. Around 1 in 10 women of reproductive age have endometriosis.

Image Credit: Lightspring/Shutterstock.com

Image Credit: Lightspring/Shutterstock.com

Symptoms are characterized by abdominal and menstrual pain (dysmenorrhoea) and infertility. Non-specific symptoms include lower back pain and pain during or after intercourse (dyspareunia). Medical treatment involves surgical removal of lesions as well as pain relief. Hormonal treatments are utilized to mitigate the effect of estrogen, including oral contraceptive pills, progesterone medication, and intrauterine devices.

SERMs

Selective estrogen receptor modulators (SERMs) can block the effects of estrogen. A review of studies up to May 2020 investigated the evidence behind the therapeutic benefits of SERMs, including only one randomized controlled trial of 93 participants. The study focused on the effect of raloxifene on the symptoms of women post lesion-removal surgery against a placebo.

It was concluded that there was no difference in outcomes for symptoms, recurrence of pain, and overall quality of life indicators. The mental health of the placebo group improved more over 12 months than the raloxifene group. The return of pain post-surgery occurred earlier for women taking the SERM treatment, and the study was prematurely concluded. There was no data to draw conclusions about fertility or focus on effects during pregnancy.

PRMs

Progesterone receptor modulators (PRMs) have antiproliferative effects on the endometrium. These are considered therapeutic agents for endometriosis. A review of studies assessed the efficacy of a range of PRM drugs up to November 2016, and this included ten random controlled trials and 960 participants.

These included mifepristone, asoprisnil ulipristal, leuprolide acetate, gestrinone, danazol, and gonadotropin‐releasing hormone (GnRH) analogs. Asoprisnil and ulipristal studies did not report quality evidence for conclusions. The remaining studies are summarised below.

Mifepristone reduced dysmenorrhoea by roughly 10% and the rate of dyspareunia - although this symptom was highlighted to be recorded as low-quality data. However, the Mifepristone group recorded 24% had hot flushes and 90% experienced amenorrhoea compared to 1% of the placebo group - this was considered high-quality evidence. Further analysis into subgroups suggests that higher doses of 5 or 10mg are more effective in improving dysmenorrhoea or dyspareunia than 2.5mg.

Two studies highlighted low-quality evidence of the efficacies of gestrinone against danazol. Gestrinone had a higher rate of hirsutism and a lower rate of breast reduction. This study showed no significant difference between the drugs for dysmenorrhoea, dyspareunia, pain relief, and secondary symptoms of hot flushes and acne

Another study of gestrinone against leuprorelin showed gestrinone was more effective on dyspareunia, amenorrhoea, and hot flushes. However, it also caused higher rates of bleeding/spotting and was less effective on dysmenorrhoea than leuprorelin. There was not sufficient evidence to advise on dose-dependent efficacy for gestrinone.

The data for the Mifepristone study was in the moderate quality range. As a result, the author concluded that Mifepristone was the only drug that could be suggested to improve dysmenorrhoea for women with endometriosis. A conclusive result on the optimal dose was not determined.

Laparoscopic surgery

Laparoscopic surgery, or keyhole surgery, is used by surgeons to access abdomen areas without making large incisions. This treatment can physically remove aberrant endometrium growths and reduce associated symptoms.

Image Credit: amab/Shutterstock.com

Image Credit: amab/Shutterstock.com

A review of studies up to April 2020 examined the efficacy of surgical intervention for endometriosis on the symptoms of pain and infertility. This review included results from 14 randomized controlled trials and 1563 women. A common limitation across the studies was the lack of clarity surrounding the method of blinding.

Overall data reports no significant improvement in pain associated with varying levels of endometriosis following surgery. None of the studies investigated the effect on live births. However, there was moderate quality evidence to suggest laparoscopic surgery increased the viability of pregnancies - although results on safety were inconclusive.

Surgery and hormonal treatment

The surgical removal of lesions and hormonal therapy may be administered to patients with endometriosis to alleviate symptoms and manage the condition. The optimal time to deliver hormonal therapy around surgical intervention remains unclear. A review was conducted to determine the most effective timeline for treatment in patients with endometriosis. This review included 25 randomized controlled trials with 3,378 women until November 2019.

Cross-study results showed that hormone therapy delivered after surgery could potentially improve conception rates, pain, and disease recurrence. Data on therapy administered before and around surgery did not produce any statistically significant conclusions. The data quality across the studies ranged from moderate to very weak.

Conclusion

There is no cure for endometriosis, but numerous treatments are available for patients. Studies regarding the safety and efficacy of these treatments, including cross-treatment comparisons, lack of quality means of gathering precise and objective data. However, the conclusions drawn from these studies can help to direct future research.

As this condition is the second most common disease for women of reproductive age, ranging from mild pain to severe symptoms of infertility, dysmenorrhoea, and dyspareunia, there is a pressing need for more conclusive research into highly effective treatments for endometriosis.

References

  • Bafort, C., Beebeejaun, Y., Tomassetti, C., Bosteels, J. and Duffy, J., 2020. Laparoscopic surgery for endometriosis. Cochrane Database of Systematic Reviews, 2020(10).
  • Chen, I., Veth, V., Choudhry, A., Murji, A., Zakhari, A., Black, A., Agarpao, C. and Maas, J., 2020. Pre- and postsurgical medical therapy for endometriosis surgery. Cochrane Database of Systematic Reviews, 2020(12).
  • Fu, J., Song, H., Zhou, M., Zhu, H., Wang, Y., Chen, H. and Huang, W., 2017. Progesterone receptor modulators for endometriosis. Cochrane Database of Systematic Reviews, 2017(7).
  • Siedlak, A., Kuc, M., Cyboran, K., Machaj, D. and Płaczek, A., 2022. complementary treatment of endometriosis: diet, physiotherapy and psychological treatment. Journal of Education, Health and Sport, 12(7), pp.989-993.
  • van Hoesel, M., Chen, Y., Zheng, A., Wan, Q. and Mourad, S., 2021. Selective oestrogen receptor modulators (SERMs) for endometriosis. Cochrane Database of Systematic Reviews, 2021(5).

Further Reading

Last Updated: Apr 10, 2023

Zainab Mustafa

Written by

Zainab Mustafa

Zainab obtained her BSc (Hons) in Medical Genetics from the University of Leicester in 2019 having completed a research project in genetic analyses of novel L1 insertions. This project focused on examining the legitimacy of novel LINE-1 sequences that had been discovered in platinum genomes using bioinformatic tools. Utilising genotyping assays, the novel insertion under scrutiny was verified, sequenced and compared to existing L1s to determine distinction and a possible lineage. Further genetic analyses were performed using ceph plate populations to begin establishing the prevalence of this transposable element amongst the individuals in these known populations.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mustafa, Zainab. (2023, April 10). Recent Advances in the Treatment of Endometriosis. News-Medical. Retrieved on July 25, 2024 from https://www.news-medical.net/health/Recent-Advances-in-the-Treatment-of-Endometriosis.aspx.

  • MLA

    Mustafa, Zainab. "Recent Advances in the Treatment of Endometriosis". News-Medical. 25 July 2024. <https://www.news-medical.net/health/Recent-Advances-in-the-Treatment-of-Endometriosis.aspx>.

  • Chicago

    Mustafa, Zainab. "Recent Advances in the Treatment of Endometriosis". News-Medical. https://www.news-medical.net/health/Recent-Advances-in-the-Treatment-of-Endometriosis.aspx. (accessed July 25, 2024).

  • Harvard

    Mustafa, Zainab. 2023. Recent Advances in the Treatment of Endometriosis. News-Medical, viewed 25 July 2024, https://www.news-medical.net/health/Recent-Advances-in-the-Treatment-of-Endometriosis.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Hydrogel implant technology offers new hope for women seeking reversible sterilization and endometriosis treatment